Literature DB >> 10797076

Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom.

S Simjee1, S E Manzoor, A P Fraise, M J Gill.   

Abstract

Forty-two high-level gentamicin-resistant (MIC > 1000 mg/L) strains of Enterococcus faecalis, isolated from diverse geographical locations throughout the UK between 1993 and 1995, were studied to identify the nature of the high-level gentamicin-resistant determinants and the possibility of these determinants being associated with a transposon. High-level gentamicin resistance was attributed to the synthesis of the bifunctional (AAC6'-APH2") aminoglycoside-modifying enzyme. The aac6'-aph2" gene, which was present on a 70 kb plasmid in all 42 isolates, could be transferred by conjugation in association with the 70 kb plasmid in 39 of the isolates studied. In three E. faecalis isolates, however, the high-level gentamicin resistance was transferable independent of the 70 kb plasmid, suggesting the presence of a conjugative transposon. Long-PCR studies showed that all 42 clinical isolates harboured a transposon similar to Tn5281, originally identified in E. faecalis strain HH22 isolated in the USA. Restriction endonuclease and Southern hybridization analysis of the UK transposon showed that it is closely related to the high-level gentamicin resistance-conferring transposon Tn5281. However, the UK transposon lacks the HaeIII site identified in Tn5281. Pulsed-field gel electrophoresis analysis identified seven different patterns. Further studies with nine restriction endonucleases showed that the aac6'-aph2" gene was associated with nine different plasmid types in E. faecalis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797076     DOI: 10.1093/jac/45.5.565

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Heteroresistance to teicoplanin in Enterococcus faecium harboring the vanA gene.

Authors:  Ting-ting Qu; Jun-li Zhang; Zhi-hui Zhou; Ze-qing Wei; Yun-song Yu; Ya-gang Chen; Lan-juan Li
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

2.  Enterococcus faecalis from patients with chronic periodontitis: virulence and antimicrobial resistance traits and determinants.

Authors:  J Sun; A Sundsfjord; X Song
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-10       Impact factor: 3.267

3.  Identification of vat(E) in Enterococcus faecalis isolates from retail poultry and its transferability to Enterococcus faecium.

Authors:  S Simjee; D G White; D D Wagner; J Meng; S Qaiyumi; S Zhao; P F McDermott
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci.

Authors:  S Simjee; D G White; P F McDermott; D D Wagner; M J Zervos; S M Donabedian; L L English; J R Hayes; R D Walker
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Antimicrobial resistance of Enterococcus spp. isolates from raw beef and meat products.

Authors:  A Sustacková; E Nápravníková; J Schlegelová
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

6.  Persistent, toxin-antitoxin system-independent, tetracycline resistance-encoding plasmid from a dairy Enterococcus faecium isolate.

Authors:  Xinhui Li; Valente Alvarez; Willis James Harper; Hua H Wang
Journal:  Appl Environ Microbiol       Date:  2011-07-22       Impact factor: 4.792

7.  In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.

Authors:  Cong-Ran Li; Xin-Yi Yang; Ren-Hui Lou; Wei-Xin Zhang; Yue-Ming Wang; Min Yuan; Yi Li; Hui-Zhen Chen; Bin Hong; Cheng-Hang Sun; Li-Xun Zhao; Zhuo-Rong Li; Jian-Dong Jiang; Xue-Fu You
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.